Hyosung Corp (004800):企業の財務・戦略的SWOT分析

◆英語タイトル:Hyosung Corp (004800) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0287
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:Industrial Goods and Machinery
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Hyosung Corp (004800) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hyosung Corp (Hyosung) is an industrial conglomerate. The company has presence in different business areas such as textiles, chemicals, industrial materials, power and industrial systems, construction, trading, and information and communication. It manufactures and sells synthetic fiber products and electronic products such as fibers, tire cords, automotive seatbelt yarns, airbag fabric, spandex, transformers, pet bottles, pumps, carpets, gear reducers and generators for power plants, and plastic wrapping films. Hyosung also manufactures wind power turbines and charging systems for alternative energy. The company has presence in South Korea, the US, Southeast Asia, Europe, South America and Africa. Hyosung is headquartered in Seoul, South Korea.

Hyosung Corp Key Recent Developments

Jun 20,2019: Hyosung Chairman Hyun-Joon Cho Discusses Business Cooperation with Vietnam’s Deputy Prime Minister
May 29,2019: Hyosung Chairman Cho Hyun-Joon Unveils First-rate Products at Chinaplas 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Hyosung Corp – Key Facts
Hyosung Corp – Key Employees
Hyosung Corp – Major Products and Services
Hyosung Corp – History
Hyosung Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Hyosung Corp – Business Description
Business Segment: Finance
Performance
Business Segment: Imported car dealer
Performance
Business Segment: Information Communication
Overview
Performance
Business Segment: Others
Performance
Business Segment: Pump Manufacturing
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: North and Central America
Performance
Geographical Segment: Other Countries
Performance
Geographical Segment: Republic of Korea
Performance
R&D Overview
Hyosung Corp – SWOT Analysis
SWOT Analysis – Overview
Hyosung Corp – Strengths
Hyosung Corp – Weaknesses
Hyosung Corp – Opportunities
Hyosung Corp – Threats
Hyosung Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Jun 20, 2019: Hyosung Chairman Hyun-Joon Cho Discusses Business Cooperation with Vietnam’s Deputy Prime Minister
May 29, 2019: Hyosung Chairman Cho Hyun-Joon Unveils First-rate Products at Chinaplas 2019
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Hyosung Corp, Key Facts
Hyosung Corp, Key Employees
Hyosung Corp, Major Products and Services
Hyosung Corp, History
Hyosung Corp, Other Locations
Hyosung Corp, Subsidiaries
Hyosung Corp, Key Competitors
Hyosung Corp, Ratios based on current share price
Hyosung Corp, Annual Ratios
Hyosung Corp, Annual Ratios (Cont...1)
Hyosung Corp, Annual Ratios (Cont...2)
Hyosung Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Hyosung Corp, Performance Chart (2014 - 2018)
Hyosung Corp, Ratio Charts

★海外企業調査レポート[Hyosung Corp (004800):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ario Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Ario Pharma Ltd (Ario) is a drug development company that develops new therapeutics for the treatment of pain. The company develops small molecule TRPA1 antagonists to treat neuropathic and inflammatory pain. Its TRPA1 activators include pungent or noxious compounds such as allyl isothiocyan …
  • Artes Biotechnology GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Artes Biotechnology GmbH (ARTES) is a developer of recombinant production cell lines and processes that is based on the microbial expression platforms. The company offers biosimilars, enzymes and proteins and vaccines. It offers technology transfer and implementation support, protein analyti …
  • Obton AS-エネルギー分野:企業M&A・提携分析
    Summary Obton A/S (Obton) is an investment company that specializes in management of assets within renewable energy. The company's investment process include screening process which inludes verification of prerequisites such as financial terms, amount of irradiation, power purchase agreement and fee …
  • Brake Bros Foodservice Limited:企業の戦略・SWOT・財務分析
    Brake Bros Foodservice Limited - Strategy, SWOT and Corporate Finance Report Summary Brake Bros Foodservice Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • KIYATEC Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary KIYATEC Inc (KIYATEC) is a biotechnology company that commercializes 3D cell culture technology. The company concentrates on data correlation to human clinical outcomes. It provides drug response profiling services for developing small molecule compounds and biologic drugs. KIYATEC offers cu …
  • Unigroup Inc:企業の戦略・SWOT・財務分析
    Unigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Unigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Nestle (Malaysia) Bhd:企業の戦略・SWOT・財務情報
    Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report Summary Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • KemPharm Inc (KMPH):製薬・医療:M&Aディール及び事業提携情報
    Summary KemPharm Inc (KemPharm) is a clinical-stage specialty pharmaceutical company that offers discovery and development of proprietary new molecular entity prodrugs. The company’s product pipeline includes KP415, methylphenidate drug for ADHD; KP201/IR, KP511/ER, KP606/IR and KP746 drugs for the …
  • 23andMe Inc-製薬・医療分野:企業M&A・提携分析
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization …
  • HollyFrontier Corporation (HFC)-石油・ガス分野:企業M&A・提携分析
    Summary HollyFrontier Corporation (HollyFrontier) is an independent energy company. It carries out crude oil refining and wholesale marketing of refined petroleum products. The company produces and markets high-value light products such as gasoline, diesel, jet fuel, specialty lubricant products, he …
  • UBS Wealth Management:企業の戦略・SWOT・財務情報
    UBS Wealth Management - Strategy, SWOT and Corporate Finance Report Summary UBS Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ascent Resources plc (AST):企業の財務・戦略的SWOT分析
    Ascent Resources plc (AST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Strides Pharma Science Ltd (STAR):企業の財務・戦略的SWOT分析
    Summary Strides Pharma Science Ltd (Strides Pharma), formerly Strides Shasun Ltd, develops and manufactures finished dosage formulations and generic pharmaceutical products. The company operates through pharma, branded generic and institutional business segments. It manufactures soft and hard gelati …
  • EnviroMission Limited (EVM)-エネルギー分野:企業M&A・提携分析
    Summary EnviroMission Limited (Enviro) is a renewable energy company that develops Solar Tower Technology (STT). It owns the license to STT across the world (excluding in China). The STT integrates the use of solar air collector and central updraft tower, to generate solar induced convective flow. I …
  • NHPC Ltd (NHPC):企業の財務・戦略的SWOT分析
    NHPC Ltd (NHPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Sakai Chemical Industry Co Ltd (4078):企業の財務・戦略的SWOT分析
    Sakai Chemical Industry Co Ltd (4078) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Lucigen Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vector …
  • Kyokuyo Co., Ltd.
    Kyokuyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyokuyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Northwest Biotherapeutics Inc (NWBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer. The company by utilizing its proprietary technology platform, DCVax, developed a robust pipeline of therapeutic product candidates. DCVax is …
  • Brickell Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Brickell Biotech Inc (Brickell Biotech) is a pharmaceutical company that develops differentiated therapeutics for the treatment of skin diseases. The company offers pipeline product candidates such as BBI-4000, BBI-5000, BBI-2000, BBI-3000 and BBI -6000. Its product candidate BBI-4000 is an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆